Dr. Ashish Baldi

Dean
Maharaja Ranjit Singh Punjab Technical University, India

Highest Degree
Ph.D. in Pharmaceutical Sciences from Maharaja Ranjit Singh Punjab Technical University, India

My URL
https://livedna.org/91.24356

Share this Profile

Area of Interest:

Pharmacology and Toxicology
Pharmaceutical Analysis
Biotechnology
Pharmaceutical Biology
Biotechnology

Selected Publications

  1. Sharma, N. and A. Baldi, 2016. Exploring versatile applications of cyclodextrins: An overview. Drug delivery, 23: 729-747.
    CrossRef  |  Direct Link  |  

  2. Kumar, B. and A. Baldi, 2016. The challenge of counterfeit drugs: A comprehensive review on prevalence, detection and preventive measures. Curr. Drug Saf., 11: 112-120.
    Direct Link  |  

  3. Kamaljeet and A. Baldi, 2016. Personalized Medicines: The Futuristic Treatment Approach. In: Integration of Life and Medical Sciences, Bansal, P. (Ed.). Adbi Parwaz Publications, India, ISBN: 978-93-85404-33-7, pp: 186-206.

  4. Arora, D., B. Arora and A. Baldi, 2016. Nanomedicines: An Overview. In: Integration of Life and Medical Sciences, Bansal, P. (Ed.). Gulab Publishers, India, ISBN: 978-93-85404-33-7, pp. 186-206.

  5. Ali, Z., N. Mishra and A. Baldi, 2016. Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria. Artif. Cell Nanomed. Biotechnol., 44: 545-549.
    CrossRef  |  Direct Link  |  

  6. Sharma, K. and K. Jeet and A. Baldi, 2015. Management of acute mountain sickness: An exploratory review on herbal d rugs. Indian J. Nat. Prod., 29: 5-94.
    Direct Link  |  

  7. Kumar, S., K. Jeet and B. Ashish, 2015. Recent technological advancements in multiparticulate formulations: The smart drug delivery systems. Asian J. Pharm., 9: S13-S25.

  8. Kumar, S. and A. Baldi, 2015. Formulation by design approach for fizzy granules using statistical optimization methodologies. Asian J. Pharm. 9: S59-S67.

  9. Kumar, D., M. Arora and A. Baldi, 2015. Understanding industrial practices for pharmaceutical quality management-I, existing approaches and guidelines. Adv. Res. Pharm. Biol., 5: 802-811.

  10. Kumar, B. and A. Baldi, 2015. Understanding industrial practices for pharmaceutical quality management-II, Process validation. Adv. Res. Pharm. Biol., 5: 812-824.

  11. Kamal, J. and A. Baldi, 2015. Approaches to overcome NSAID induced ulceration in arthritic pain management: Perspectives and prospects. J. Drug Delivery Ther., 5: 9-16.

  12. Baldi, A., M.S. Panwar and S. Goyal, 2015. Development and validation of spectrophotometric method for determination of ropinirole hydrochloride in bulk and formulation. Inv. Rapid Pharm. Analysis Q. Assur., 2015: 1-4.
    Direct Link  |  

  13. Arora, M., S. Sharma and A. Baldi, 2015. Regulatory categories of probiotics across the globe: A review representing existing and recommended categorization. Indian J. Med. Microbiol., 33: 2-10.
    CrossRef  |  Direct Link  |  

  14. Arora, M., A. Baldi and D. Singh, 2015. Existing Regulatory Regimes for Traditional Products with Health Claims: Insights and Prospects. In: Potentials and Bottlenecks in Clinical Trials of Herbal Drugs, Bansal, P. and S.E. Reddy (Eds.). Gulab Publishers, India, ISBN: 978-81-920643-9-0, pp: 32-50.

  15. Arora, M. and A. Baldi, 2015. Regulatory categories of probiotics across the globe: A review representing existing and recommended categorization. Indian J. Med. Microbial., 33: 2-10.
    Direct Link  |  

  16. Arora, M. and A. Baldi, 2015. Good manufacturing practice regulations for probiotic based pharmaceuticals: Current scenario and suggestive recommendations. Applied Clin. Res. Clin. Trial Regul. Affairs, 2: 165-175.
    Direct Link  |  

  17. Arora, M. and A. Baldi, 2015. Comparative account of quality management and regulatory aspects of products with health claims: Existing approaches and future challenges for probiotics and herbal products. Applied Clin. Res. Clin. Tria. Regul. Affair, 2: 123-132.
    Direct Link  |  

  18. Mishra, N., D. Singh, S. Sharma and A. Baldi, 2014. Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery. Curr. Drug Delivery, 11: 729-743.
    Direct Link  |  

  19. Bhandari, S. and A. Baldi, 2014. Total quality management of pharmaceuticals: Recent approaches and advancements. Adv. Res. Pharm. Biol., 4: 655-663.

  20. Thakur, S., S. Sharma, S. Kumar, U. Singh and A. Baldi, 2013. Artemisinin: The ‘Molecule of Hope’ for treatment of malaria. Pharm. Aspire, 4: 84-89.

  21. Singh, U. and A. Baldi, 2013. Simultaneous estimation of quercetin and silymarin: Method development and validation. Int. J. Pharm. Biol. Archive, 4: 527-531.

  22. Sharma, S., M. Arora and A. Baldi, 2013. Probiotics in India: Current status and future prospects. Pharm. Aspire, 4: 68-77.

  23. Sharma, P., D. Joshi, A. Baldi, K. Khatri and D. Dubey, 2013. White tea: Offering something new to your health. Pharm. Aspire, 4: 54-60.

  24. Kumar, S. and A. Baldi, 2013. Pharmacovigilance in India: Perspectives and prospects. J. Drug Delivery Ther., 3: 237-246.

  25. Kumar, S. and A. Baldi, 2013. Pharmacoeconomics: Principles, methods and economic evaluation of drug therapies. Pharm. Tech. Med., 2: 362-369.

  26. Kumar, S. and A. Baldi, 2013. Design of experiment based statistical optimization in life science research: An overview. Pharm. Aspire, 4: 35-43.

  27. Baldi, A., N. Choudhary and S. Kumar, 2013. Nutraceuticals as therapeutic agents for holistic treatment of diabetes. Int. J. Green Pharm., 7: 278-287.
    CrossRef  |  Direct Link  |  

  28. Baldi, A. and S. Kumar, 2013. Water for Pharmaceutical Uses: Quality Control and Validation. In: Water for Health, Gill, S.S., P. Bansal and R. Manhas (Eds.). Basera Verlag, Munchen, Germany, pp: 236-255.

  29. Baldi, A. and N. Choudhary, 2013. In vitro antioxidant and hepatoprotective potential of Chenopodium album extract. Int. J. Green Pharm., 7: 50-56.
    CrossRef  |  Direct Link  |  

  30. Arora, M., S. Sharma and A. Baldi, 2013. Comparative insight of regulatory guidelines for probiotics in USA, India and Malaysia: A critical review. Int. J. Biotechnol. Well. Ind., 2: 51-64.
    CrossRef  |  Direct Link  |  

  31. Sumit, K., T. Shikha, T. Deepika and B. Ashish, 2012. A quantitative approach for pharmaceutical quality by design patterns. Inveti Rapid Pharm. Analysis Q. Assur., 2012: 1-8.

  32. Sumit, K., S. Vivek, S. Sujata and B. Ashish, 2012. Herbal cosmetics: Used for skin and hair. Inven. J., 2012: 1-7.

  33. Baldi, A., M. Pandit and P. Ranka, 2012. Amelioration of in vivo antioxidant activity of banana extracts. IJPBA, 3: 157-161.

  34. Saini, K., N. Saini and A. Baldi, 2011. Impact of anti-counterfeiting trade agreement on pharma sector: A global perspective. J. Curr. Pharm. Res., 6: 4-10.

  35. Baldi, A., M.S. Panwar and R. Gupta, 2011. Evaluation of in vitro antioxidant activity of Eclipta alba. Int. J. Pharma. Biol. Arch., 2: 767-771.

  36. Baldi, A. and S. Goyal, 2011. Hypoglycemic effect of polyherbal formulation in alloxan induced diabetic rats. Pharmacologyonline, 3: 764-773.
    Direct Link  |  

  37. Bagherwal, A., A. Baldi, R.K. Nagar and D.K. Patidar, 2011. Synthesis and antimicrobial studies of azetidinone derivatives from naphthylamine moiety. Synthesis, 3: 274-279.

  38. Farkya, S., A. Baldi, V. Kumar, V. Datta and R. Mehra et al., 2010. Impact of symbiotic fungi on production of secondary metabolites by plant cell culture, Asia Pacific. J. Mol. Biol. Biotechnol., 18: 51-53.

  39. Baldim, A., D. Goyal, M. Choudhary and A. Mobiya, 2010. Effect of Chenopodium album extract in paracetamol induced hepatotoxicity in rats. Int. J. Pharm. Sci. Biotech., 1: 223-227.

  40. Baldi, A., W. Hussain and Y. Tailor, 2010. Evaluation of in-vitro cultured cells of Withania somniferafor antioxidant activity. Curr. Trend Biotechnol. Pharm., 4: 589-595.

  41. Baldi, A., S. Farakya, A. Jain, N. Gupta and R. Mehra et al., 2010. Enhanced production of podophyllotoxins by co-culture of transformed Linum album cells with plant growth promoting fungi. Pure Applied Chem., 82: 227-241.

  42. Baldi, A., N. Choudhary, J. Maru and R. Joshi, 2010. Effect of pumpkin concentrate on alloxan induced diabetic rats. J. Global Pharma Technol., 2: 24-27.

  43. Baldi, A., A.K. Patidar and J. Sanadya, 2010. Method development and validation for estimation of quetiapine fumarate by RP-HPLC. Asian J. Res. Chem., 3: 604-607.
    Direct Link  |  

  44. Baldi, A., 2010. Computational approaches for drug design and discovery: An overview. Syst. Rev. Pharm., 1: 99-105.
    CrossRef  |  Direct Link  |  

  45. Baldi, A., A.K. Srivastava and V.S. Bisaria, 2009. Fungal Elicitors for Enhanced Production of Secondary Metabolites in Plant Cell Suspension Cultures. In: Symbiotic Fungi, Varma, A.K. and A.C. Kharkwal (Eds.). Springer-Verlag, Heidelburg, ISBN: 978-3-540-95893-2, pp: 373-380.

  46. Baldi, A., A. Jain, N. Gupta, A.K. Srivastava and V.S. Bisaria, 2009. Coculture of Linum album Cells and Piriformospora indica for Improved Production of Phytopharmaceuticals. In: Symbiotic Fungi, Varma, A.K. and A.C. Kharkwal (Eds.). Springer-Verlag, Heidelburg, ISBN: 978-3-540-95893-2, pp: 361-372.

  47. Baldi, A., 2009. Erectile dysfunction and ayurveda. J. Res. Educ. Indian Med., 14: 15-24.

  48. Ashish, B. and T. Yogendra, 2009. Pharmacogenomics and its impact on drug discovery. J. Global Pharm. Technol., 1: 26-36.

  49. Bisaria, V.S., A. Baldi, V. Kumar, N. Gupta, A. Jain, S. Farkya and A.K. Srivastava, 2008. Interaction of phytopromotional fungi and plant cells on synthesis of plant-derived metabolites. J. Biotechnol., 136: S11-S11.
    CrossRef  |  Direct Link  |  

  50. Baldi, A., V.S. Bisaria and A.K. Srivastava, 2008. Biotechnological Approaches for Production of Some Plant based Chemotherapeutics. In: Medicinal Plant Biotechnology, Kayser, O. and W.J. Quax (Eds.). Wiley-VCH Verlag, Germany, ISBN: 978-3-527-31443-0, pp: 117-156.

  51. Baldi, A., D. Singh and V.K. Dixit, 2008. Dual elicitation for improved production of withaferin a by cell suspension cultures of Withania somnifera. Applied Biochem. Biotechnol., 151: 556-564.
    Direct Link  |  

  52. Baldi, A., A.K. Srivastava and V.S. Bisaria, 2008. Improved podophyllotoxin production by transformed cultures of Linum album. Biotechnol. J., 3: 1256-1263.
    CrossRef  |  Direct Link  |  

  53. Baldi, A., A.K. Srivastava and V.S. Bisaria, 2008. Effect of aeration on production of anticancer lignans by cell suspension cultures of Linum album. Applied Biochem. Biotechnol., 151: 547-555.
    Direct Link  |  

  54. Baldi, A., A. Jain, N. Gupta, A.K. Srivastava and V.S. Bisaria, 2008. Co-culture of arbuscular mycorrhiza-like fungi (Piriformospora indica and Sebacina vermifera) with plant cells of Linum album for enhanced production of podophyllotoxins: A first report. Biotechnol. Lett., 30: 1671-1677.
    Direct Link  |  

  55. Baldi, A. and V.K. Dixit, 2008. Enhanced production of artemisinin by cell cultures of Artemisia annua. Curr. Trend Biotechnol. Pharm., 2: 341-348.

  56. Baldi, A. and V. Dixit, 2008. Yield enhancement strategies for artemisinin production by suspension cultures of Artemisia annua. Bioresour. Technol., 99: 4609-4614.
    CrossRef  |  Direct Link  |  

  57. Baldi, A., S. Saraf and S. Saraf, 2007. Garlic: A better substitute for Viagra. Sanjeevani Med. Times, 4: 66-68.

  58. Baldi, A., 2007. Medical tourism in India: Opportunities unlimited, Sanjeevani Med. Times, 10: 70-75.

  59. Baldi, A., 2007. Erectile dysfunction and its treatment. Sanjeevani Med. Times, 4: 34-37.

  60. Baldi, A., 2006. Drug discovery and computer aided drug design. JNPA, 24: 1-16.

  61. Baldi, A. and V.K. Dixit, 2006. Enhanced production of artemisinin by hairy root cultures of Artemisia annua L. JNPA, 24: 27-38.

  62. Baldi, A., R.S. Pandey and J. Madan, 2002. Parkinsonism: History and novel biotech approach. J. Sci. Pharm., 3: 62-65.

  63. Baldi, A., S. Saraf and S. Saraf, 2001. Viagra and garlic: A comparative study. Eastern Pharmacist, 44: 35-38.
Member since June, 2018